04
Apr
Rivaroxaban Mechanism Of Action. Rivaroxaban competitively inhibits Factor Xa and is more than 10000-fold more selective for Factor Xa than other related serine proteases and it does not require cofactors such as antithrombin to exert its. Rivaroxaban competitively inhibits Factor Xa and is more than 10000-fold more selective for Factor Xa than other related serine proteases and it does not require cofactors such as antithrombin to exert its anticoagulant effect. Mechanism of action Rivaroxaban competitively inhibits free and clot bound factor Xa. 15 mg 42s and 20 mg 9s 51 ea Pharmacology Mechanism of Action.
Inhibits platelet activation and fibrin clot formation via direct selective and reversible inhibition of factor Xa FXa in both the intrinsic and extrinsic coagulation pathways. Rivaroxaban was the first oral direct factor Xa inhibitor. Mechanism of action Rivaroxaban competitively inhibits free and clot bound factor Xa. Rivaroxaban the first oral direct Factor Xa inhibitor is a small-molecule oxazolidinone derivative that binds directly and reversibly to Factor Xa via the S1 and S4 pockets. Rivaroxaban the first oral direct Factor Xa inhibitor is a small-molecule oxazolidinone derivative that binds directly and reversibly to Factor Xa via the S1 and S4 pockets. Rivaroxaban is a selective inhibitor of factor Xa FXa.
Concurrent use of a single dose of rivaroxaban and another combined P-gp and strong CYP3A4 inhibitor resulted in significant increases in the steady-state rivaroxaban AUC and Cmax.
Rivaroxaban competitively inhibits Factor Xa and is more than 10000-fold more selective for Factor Xa than other related serine proteases and it does not require cofactors such as antithrombin to exert its anticoagulant effect. Rivaroxaban is the first oral anticoagulant with a direct anti-Xa activity to be registered approval. It blocks Factor Xa directly and reversibly. Thromb Res 2011 127. Rivaroxaban is a unqiue anticoagulant for two reasons. It is an oxazolidinone derivative that binds directly and reversibly to factor Xa via the S1 and S4 pockets see Figure 2.